ReferenceID 4442
Acteoside promotes B cell-derived IL-10 production and ameliorates autoimmunity
J Leukoc Biol
IL-10-producing regulatory B (Breg) cells are well recognized for maintaining immune tolerance. The impaired Breg cell function with decreased IL-10-producing capacity has been found in autoimmune diseases, such as rheum
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final reference record.
- Reference Id
- 4442
- Evidence Id
- 21032
- Core Evidence Id
- 21032
- Source Reference Id
- 2168
- Herb2 Reference Id
- HBREF002965
- Subject Paper Key
- HBIN014630_35638582
- Pubmed Id
- 35638582
- Doi
- 10.1002/JLB.3MA0422-510R
- Paper Title
- Acteoside promotes B cell-derived IL-10 production and ameliorates autoimmunity
- Paper Abstract
- IL-10-producing regulatory B (Breg) cells are well recognized for maintaining immune tolerance. The impaired Breg cell function with decreased IL-10-producing capacity has been found in autoimmune diseases, such as rheumatoid arthritis, lupus, and primary Sjogren's syndrome (pSS). However, seldom therapeutic agents targeting Breg cells are available to treat those autoimmune diseases. Here, we showed that acteoside (AC), a caffeoyl phenylethanoid glycoside from a medicinal herb Radix Rehmanniae, could promote IL-10 production from both human and murine B cells via critically regulating the TLR4/PI3K axis. Moreover, TLR4 was found increased in Breg cells from mice with experimental SS (ESS), a mouse model that recapitulates human pSS. Thus, B cells from the ESS mice were susceptible to AC treatment, showing higher IL-10-producing capacity than those from naïve controls. In addition, AC treatment also promoted the production of IL-10 from TLR4 + CXCR4 + plasma cells of ESS mice. Notably, we found that AC was able to enter lymphoid organs upon oral administration. AC treatment effectively increased IL-10 + B cells in ESS mice and ameliorated disease pathology accompanied by reduced T effector cells, including Th17 and T follicular helper cells in the ESS mice. In conclusion, AC could promote Breg cell function and attenuate ESS pathology in vivo, which may be a promising drug candidate for treating pSS and other autoimmune diseases.
- Journal
- J Leukoc Biol
- Publish Year
- 2022
- Experiment Subject
- mouse; human; breg cells
- Experiment Type
- Animal Experiment
- Phenotype Related
- Lupus; Autoimmune Diseases; Rheumatoid Arthritis; Pss; Sjogren's Syndrome
- Paper Title Cn
- Paper Title En
- Acteoside promotes B cell-derived IL-10 production and ameliorates autoimmunity
- Bilingual Status
- semi_complete